Remove Biotech Remove Hardware Remove Marketing
article thumbnail

Stämm Biotech raises $17M for its next-generation, 3D printed bioreactor

TechCrunch

Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Image Credits: Stämm Biotech. And, as of writing, Ginkgo’s market cap was closer to $7.24 Image Credits: Stämm Biotech.

Biotech 226
article thumbnail

The Case For Revenue-Focused Platforms In The Life Sciences

Crunchbase News

By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device. Does the market see value in the tool today, or do you need to educate? What is your superpower?

Biotech 113
article thumbnail

As healthcare goes remote, Equipt Health brings medical hardware to the home

TechCrunch

.” In addition to proving a more integrated path for patients, Equipt partners with medical device companies looking to go to market. Once a company is ready to launch medically cleared equipment, the company can market the product on its site to help fulfill demand.

Hardware 227
article thumbnail

Glyphic Biotechnologies raises $6M to accelerate protein sequencing by orders of magnitude

TechCrunch

The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Going from service to hardware sales and support is the current roadmap. Berkeley has a big new biotech incubator in Bakar Labs.

Biotech 249
article thumbnail

Ultima Genomics claims $100 full genome sequencing after stealth $600M raise

TechCrunch

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. This could push the price lower, but for now a 90% reduction is more than enough to go to market with.

Biotech 315
article thumbnail

SOSV partners explain how deep tech startups can fundraise successfully

TechCrunch

At TechCrunch Early Stage: Marketing and Fundraising, two experienced investors spoke on the subject and advised startups facing a challenging fundraising path. Pae Wu and Garrett Winther are both partners at SOSV and run the fund’s programs around biotech and hardware.

article thumbnail

The Week’s 10 Biggest Funding Rounds: Another Big Week For Biotech As Tome Raises $213M

Crunchbase News

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.

Biotech 120